NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 341 filers reported holding NEOGENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.19 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $140,000 | +4.5% | 16,270 | -0.8% | 0.00% | – |
| Q2 2022 | $134,000 | -32.3% | 16,404 | +0.7% | 0.00% | – |
| Q1 2022 | $198,000 | -65.3% | 16,293 | -2.8% | 0.00% | -100.0% |
| Q4 2021 | $571,000 | -15.8% | 16,758 | +19.2% | 0.00% | -50.0% |
| Q3 2021 | $678,000 | +8.7% | 14,057 | +1.8% | 0.00% | 0.0% |
| Q2 2021 | $624,000 | -3.1% | 13,812 | +3.4% | 0.00% | 0.0% |
| Q1 2021 | $644,000 | -13.3% | 13,355 | -3.3% | 0.00% | 0.0% |
| Q4 2020 | $743,000 | +42.6% | 13,809 | -2.2% | 0.00% | 0.0% |
| Q3 2020 | $521,000 | -8.0% | 14,119 | -22.8% | 0.00% | 0.0% |
| Q2 2020 | $566,000 | +84.4% | 18,281 | +64.4% | 0.00% | +100.0% |
| Q1 2020 | $307,000 | -5.8% | 11,122 | -0.3% | 0.00% | 0.0% |
| Q4 2019 | $326,000 | +54.5% | 11,158 | +1.3% | 0.00% | 0.0% |
| Q3 2019 | $211,000 | -10.6% | 11,018 | +2.5% | 0.00% | 0.0% |
| Q2 2019 | $236,000 | – | 10,753 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,516,313 | $14,011 | 8.43% |
| Greenhouse Funds LLLP | 2,795,231 | $25,827,934 | 2.36% |
| First Light Asset Management, LLC | 2,682,171 | $24,783,260 | 2.30% |
| PERKINS CAPITAL MANAGEMENT INC | 197,700 | $1,827 | 1.93% |
| Altium Capital Management LP | 285,000 | $2,633,400 | 1.34% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 1,654,543 | $15,287,977 | 0.95% |
| EMERALD ADVISERS, LLC | 2,101,567 | $19,418,479 | 0.94% |
| Bullseye Asset Management LLC | 105,997 | $980 | 0.53% |
| OAK FAMILY ADVISORS, LLC | 101,194 | $935,033 | 0.50% |
| FORMULA GROWTH LTD | 180,300 | $1,665,972 | 0.47% |